daclatasvir dihydrochloride
Daclatasvir is a direct-acting antiviral agent against Hepatitis C Virus used for the treatment of chronic HCV genotype 1 and 3 infection. It is sold under the trade name Daklinza.. Reference standards of Daclatasvir Dihydrochloride API, and its pharmacopeial, non pharmacopeial impurities, and stable isotopes are listed below
stdClass Object
(
[pname] => Daclatasvir Dihydrochloride - API Standards
[catalogue_number] => PA 31 39000
[category_ids] => ,80,77,78,70,82,
[chemical_name] =>
[weight] => 811.80
[form] => C40H52Cl2N8O6
[cas] => 1009119-65-6
[pslug] => 1009119-65-6-daclatasvir-dihydrochloride-api-pa3139000
[latest_product] => 0
[linkproducts] => 1
[offers_id] => 1
[offers_name] => Spring Season Offer
[offers_status] => 1
[offers_start_date] => 2024-03-27
[offers_end_date] => 2024-03-31
[pageview] => 2
[offers_slug] => spring-season-offer
[offers_product_id] => 6008
[offers_product_code] => PA 31 39000
[offers_master_id] => 1
[offer_percentage] => 20% OFF
[offers_product_main_cat] => Pharmaceutical Reference Standards
)
Daclatasvir Dihydrochloride - API Standards
Catalogue No.:PA 31 39000
Molecular Formula : C40H52Cl2N8O6
Molecular Weight : 811.80